1. HPLC for Pharmaceutical Scientists, Kazakevich, Y., Lobrutto, R., Eds., New York: Willey, 2007.
2. Kostarnoi, A.V., Golubitskii, G.B., Basova, E.M., Budko, E.V., and Ivanov, V.M., J. Anal. Chem., 2008, vol. 63, no. 6, p.516.
3. Rukovodstvo po ekspertize lekarstvennykh sredstv (Guidelines for the Examination of Medicinal Products), Moscow: Poligraf-Plyus, 2014, vol.3.
4. Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System, Revision 1, Rockville, MD: US. Department of Health and Human Services, FDA, Center for Drug Evaluation and Research (CDER), 2015.
5. Guidance on the Investigation of Bioequivalence, European Medicines Agency (EMA), Committee for Medicinal Products of Human Use (CHMP), 2010.